Thank you to our 13,000+ employees who served their local #communities during Week of Possibilities, the AbbVie Foundation’s annual #volunteer event. Together they spent nearly 50,000 hours contributing to numerous community projects around the globe, including renovating and improving schools, serving meals, building homes, cleaning up waterways and more. See the full impact of their volunteering: https://bit.ly/4dyXFoQ #AbbVieGivesBack [Video description: Interviews with AbbVie employees talking about volunteering during Week of Possibilities and footage of volunteer activities.]
About us
AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics and other areas of unmet need. Learn more about us at www.abbvie.com and review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html.
- Website
-
http://www.abbvie.com
External link for AbbVie
- Industry
- Pharmaceutical Manufacturing
- Company size
- 10,001+ employees
- Headquarters
- North Chicago, Illinois
- Type
- Public Company
- Specialties
- Biopharmaceutical, Biotechnology, Innovation, Research and Development, Manufacturing, Biotherapeutics, Oncology, Immunology, Virology, Neuroscience, Womens Health, Aesthetics, and Eye Care
Locations
Employees at AbbVie
Updates
-
How long does it take to bring new #treatments from discovery, to clinical development, and then to patients? The answer: an average of 10-15 years. That’s why we’re challenging conventional timelines to cut that process in half. Learn more: https://bit.ly/3yhUNOq
-
NEWS: American Society of Hematology's journal, Blood, published updated results from a Phase 3 study, which includes six-year follow-up data in #patients with previously untreated chronic lymphocytic leukemia (#CLL). Learn more about the findings: https://bit.ly/3LPPUPB [Video description: On-screen text reads, “Oncology News.”]
-
To celebrate our #interns' great work this summer, we hosted a picnic on National Intern Day at our North Chicago HQ. Explore our #internship opportunities and see why we were named to WayUp and Yello.co's list of Top 100 Internship Programs of 2024: https://bit.ly/3WNax5i #AbbVieLife [Video description: Six AbbVie interns jumping over the video frame to transition from their workspace to an outdoor picnic.]
-
Cerevel Therapeutics is now part of AbbVie. Learn how this #acquisition strengthens our #neuroscience pipeline, continuing our mission to transform standards of care across neurological and psychiatric conditions. Explore: https://abbv.ie/53b6c2 $ABBV [Image description: On-screen text reads, "Cerevel is now part of AbbVie. Completion of acquisition adds pipeline of assets to complement our neuroscience portfolio. Click the link to learn more."]
-
We’re striving to make a difference for people impacted by #IBD. Learn how we’re working to reimagine the standards of care through innovation and research: https://abbv.ie/cb1af7 #UlcerativeColitis #CrohnsDisease [Image description: Roopal Thakkar, M.D., EVP, R&D, Chief Scientific Officer, AbbVie, says, "We are committed to strengthening our diversified inflammatory bowel disease (IBD) portfolio, providing healthcare professionals with more options to treat their IBD patients."]
-
ICYMI: Members of our executive leadership team discussed our Q2 2024 #FinancialResults during last week’s #earnings call. Swipe to learn more about our performance from our leaders. $ABBV [Image description: Members of AbbVie’s executive leadership team share their remarks on our Q2 2024 Financial Results, including: Robert A. Michael, Jeffrey R. Stewart, Carrie Strom, Roopal Thakkar and Scott T. Reents.]
-
Millions of people worldwide are living with #HepatitisC. On #WorldHepatitisDay, learn about our commitment to treating #HCV and the role of partnerships to achieve the World Health Organization’s HCV elimination goal by 2030. ⬇ [Video description: Interview with Brian Conway, medical director, Vancouver Infectious Diseases Centre. On-screen text reads, “Globally, an estimated 50 million people have HCV, with about 1 million new infections occurring per year. Join us as we work to help eliminate Hepatitis C.”]
-
To effectively work together to find cures, researchers need a shared understanding of what a cure really is – and what it isn’t. See what our researchers look for and how they collaborate to find cures faster: https://bit.ly/3LG7rtt #WorldHepatitisDay [Video description: On-screen text reads, “The pathway to a cure” followed by 5 steps along the pathway: precedented symptom relief; unprecedented symptom relief; transformative therapies; on treatment, disease-free state; cure.]
-
JUST IN: The European Medicines Agency approved our latest treatment for adults with moderately to severely active #UlcerativeColitis. Read more: https://bit.ly/3WnZb6x #IBD [Video description: On-screen text reads, “Immunology News. European Commission Approval in Ulcerative Colitis.”]